Demographics of HIV-1 infection in Denmark: Results from the Danish HIV Cohort Study

References

• Sarngadharan MG, DeVico AL, Bruch L, Schupbach J, Gallo RC. HTLV-III: the aetiological agent of AIDS. Princess Takamatsu Symp 1984;15:301–8.
   PubMedGoogle Scholar
• O’Brien WA, Hartigan PM, Martin D, Esinhart J, Hill A, Benoit S, et al. Changes in plasma HIV-1 RNA and CD4 + lymphocyte counts and the risk of progression to AIDS. Veterans Affairs Cooperative Study Group on AIDS. N Engl J Med 1996;334: 426–31.
   Google Scholar
• Mocroft A, Youle M, Morcinek J, Sabin CA, Gazzard B, Johnson MA, et al. Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. Br Med J 1997;314:409–13.
   Google Scholar
• Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe. Lancet 2000; 355:1131–7.
   PubMed Web of Science ®Google Scholar
• Chiesi A, Mocroft A, Dally LG, Miller V, Katlama C, Ledergerber B, et al. Regional survival differences across Europe in HIV-positive people: the EuroSIDA study. AIDS 1999;13:2281–8.
   PubMed Web of Science ®Google Scholar
• Egger M, May M, Chene G, Phillips AN, Ledergerber B, Dabis F, et al. Prognosis of HIV-1-infected patients starting highly active antiretroviral therapy: a collaborative analysis of prospective studies. Lancet 2002;360:119–29.
   PubMed Web of Science ®Google Scholar
• Lucas GM, Chaisson RE, Moore RD. Survival in an urban HIV-1 clinic in the era of highly active antiretroviral therapy: a 5-y cohort study. J Acquir Immune Defic Syndr 2003; 33:321–8.
   Google Scholar
• Phillips AN, Grabar S, Tassie JM, Costagliola D, Lundgren JD, Egger M. Use of observational databases to evaluate the effectiveness of antiretroviral therapy for HIV infection: comparison of cohort studies with randomized trials. EuroSIDA, the French Hospital Database on HIV and the Swiss HIV Cohort Study Groups. AIDS 1999;13:2075–82.
   Google Scholar
• Easterbrook PJ. Research potentials and pitfalls in the use of an HIV clinical database: Chelsea and Westminster Hospital. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17(Suppl 1):S28–33.
   PubMedGoogle Scholar
• Vandenbroucke JP. When are observational studies as credible as randomized trials? Lancet 2004;363:1728–31.
   PubMed Web of Science ®Google Scholar
• Jensen-Fangel S, Pedersen C, Larsen CS, Tauris P, Møller A, Obel N. Changing demographics in an HIV-infected population: results from an observational cohort study in western Denmark. Scand J Infect Dis 2001;33:765–70.
   Google Scholar
• Statistics Denmark. Available at: http://www.statistikbanken. dk/BEF1A. Accessed 30 August 2004.
   Google Scholar
• Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 1998;338:853–60.
   PubMed Web of Science ®Google Scholar
• Mocroft A, Katlama C, Johnson AM, Pradier C, Antunes F, Mulcahy F, et al. AIDS across Europe, 1994–98: the EuroSIDA study. Lancet 2000;356:291–6.
   PubMed Web of Science ®Google Scholar
• HIV/AIDS Annual Report 2002. EPI-NEWS 2003; 34. Statens Seruminstitut, Copenhagen. Available at: http://www.ssi.dk/graphics/en/news/epinews/2003/pdf/2003_34_hivaids.pdf Accessed 30 August 2004.
   Google Scholar
• Steinbrook R. The AIDS epidemic in 2004. N Engl J Med 2004;351:115–7.
   PubMed Web of Science ®Google Scholar
• Dragsted UB, Mocroft A, Vella S, Viard JP, Hansen AB, Panos G, et al. Predictors of immunological failure after initial response to highly active antiretroviral therapy in HIV-1-infected adults: a EuroSIDA Study. J Infect Dis 2004; 190:148–55.
   PubMed Web of Science ®Google Scholar
• Jensen-Fangel S, Pedersen L, Pedersen C, Larsen CS, Tauris P, Møller A, et al. Low mortality in HIV-infected patients starting HAART in advance of immunological deterioration: a comparison with the general population. AIDS 2004;18: 89–97.
   Google Scholar
• WHO, UNAIDS. AIDS Epidemic Update. 2003. Available at: http://www.unaids.org/Unaids/EN/Resources/Publications/corporate+publications/aids+epidemic+update+-december+2003.asp Accessed 30 August 2004.
   Google Scholar